Medicels SRL
Medicels reported total assets of €1.93m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026).
The score of Medicels shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets +81 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medicels's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Medicels's financial analysis
- Solvency61.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medicels
Medicels's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0842.016.418
- VAT number
- BE0842016418
- Peppol
- Registered · 0208:0842016418 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Dec 2011
- Registered office
- 2950 Kapellen
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medicels (SRL) has been based in Kapellen since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 293,305 € and equity of €1.18m; its revenue is not published. Its solvency stands at 61.2%, above the median of its sector (44.2%).
Companies similar to Medicels
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE L'Entreville Retail sale of pharmaceutical products Lobbes · balance sheet €1.92m
- Apotheek Martens Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet €1.92m
- Virco Pharma Retail sale of pharmaceutical products Hoeilaart · balance sheet €1.92m
- Ludaphar Retail sale of pharmaceutical products Beauvechain · balance sheet €1.80m
- Extrapharm Tilff Retail sale of pharmaceutical products Esneux · balance sheet €1.91m
- Geassocieerde Apotheek Schoten Retail sale of pharmaceutical products Schoten · balance sheet €1.91m
- Opniphar Retail sale of pharmaceutical products Buggenhout · balance sheet €1.90m
- Simon Immo Retail sale of pharmaceutical products Écaussinnes · balance sheet €1.96m
Frequently asked questions about Medicels
What is the revenue of Medicels?
Medicels files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medicels?
In Belgium, the VAT number is the company number prefixed with BE: BE0842016418 for Medicels, if the company is VAT-registered. Its company number (CBE) is 0842.016.418.
Where is the registered office of Medicels?
According to the CBE register, the registered office of Medicels is in 2950 Kapellen.
What is the equity of Medicels?
At the close of the 2025 financial year, the equity of Medicels amounts to 1,179,926 €, a solvency of 61.2% of total assets.
Who manages Medicels?
The register lists 1 active mandates at Medicels. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medicels
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →